Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 4Breast 3Genitourinary 2Gastrointestinal 1

Conditions

Breast Neoplasms 543Triple Negative Breast Neoplasms 97Ovarian Neoplasms 58Colorectal Neoplasms 50Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 44Neoplasms 38Lung Neoplasms 33Melanoma 29Endometrial Neoplasms 29Neoplasm Metastasis 28Stomach Neoplasms 26Pancreatic Neoplasms 26Uterine Cervical Neoplasms 25Squamous Cell Carcinoma of Head and Neck 22Colonic Neoplasms 20Head and Neck Neoplasms 18Carcinoma, Renal Cell 18Esophageal Neoplasms 16Sarcoma 14Advanced Breast Cancer 14Small Cell Lung Carcinoma 13Urinary Bladder Neoplasms 12Liver Neoplasms 11Carcinoma, Transitional Cell 11Kidney Neoplasms 10Carcinoma, Intraductal, Noninfiltrating 10Brain Neoplasms 10Lymphedema 9Anatomic Stage I Breast Cancer AJCC v8 9

Interventions

nilotinib 1Paclitaxel 1Laparoscopy 1Fulvestrant 1Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × Breast × 30 days × Clear all
NCT07038369 2026-06-03

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Atavistik Bio, Inc

Phase 1 Active not recruiting
134 enrolled
BreastGenitourinaryGynecologic

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06533059 2026-05-26

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

Alterome Therapeutics, Inc.

Phase 1 Active not recruiting
110 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡